Intracellular DNA sensors in immunity

Current Opinion in Immunology

Volumn 20, Issue 4, 2008, Pages 383-388

  Takeshita, Fumihiko ^a   Ishii, Ken J ^b,c  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; CATHELICIDIN; CHLOROQUINE; DNA B; DNA VACCINE; DOUBLE STRANDED DNA; INTERFERON; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHOTRANSFERASE; SINGLE STRANDED DNA; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; ENDOSOME; HUMAN; IMMUNOCOMPETENT CELL; INFECTION; INNATE IMMUNITY; INTRACELLULAR SPACE; MOLECULAR SENSOR; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CARD SIGNALING ADAPTOR PROTEINS; DNA; DNA-BINDING PROTEINS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 48549091581     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.05.009     Document Type: Review

References (49)

1. Isaacs A., Cox R.A., and Rotem Z. Foreign nucleic acids as the stimulus to make interferon. Lancet 2 (1963) 113-116
2. Rotem Z., Cox R.A., and Isaacs A. Inhibition of virus multiplication by foreign nucleic acid. Nature 197 (1963) 564-566
3. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T., et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72 (1984) 955-962
4. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
5. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
6. Hemmi H., Kaisho T., Takeda K., and Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 170 (2003) 3059-3064
7. Suzuki K., Mori A., Ishii K.J., Saito J., Singer D.S., Klinman D.M., Krause P.R., and Kohn L.D. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A 96 (1999) 2285-2290
8. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7 (2006) 40-48
9. Stetson D.B., and Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24 (2006) 93-103
10. Yoshida H., Okabe Y., Kawane K., Fukuyama H., and Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 6 (2005) 49-56
11. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., Yoshikawa H., and Nagata S. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006) 998-1002
12. Ishii K.J., Kawagoe T., Koyama S., Matsui K., Kumar H., Kawai T., Uematsu S., Takeuchi O., Takeshita F., Coban C., et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451 (2008) 725-729. This report is the first evidence that DNA vaccine immunogenicity is controlled by the newly identified TLR9-independent, TBK1-mediated innate immune response to dsDNA, and that was independent of DAI, recently identified as a cytosolic sensor for DNA.
13. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., Monks B.G., McKnight C.J., Lamphier M.S., Duprex W.P., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8 (2007) 772-779
14. Kumagai Y., Takeuchi O., and Akira S. TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60 (2008) 795-804
15. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., and Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
16. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7 (2007) 353-364
17. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., Takayanagi H., Ohba Y., Taniguchi T., and Honda K. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A 103 (2006) 15136-15141
18. Schmitz F., Heit A., Guggemoos S., Krug A., Mages J., Schiemann M., Adler H., Drexler I., Haas T., Lang R., et al. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol 37 (2007) 315-327
19. Ashman R.F., and Lenert P. Structural requirements and applications of inhibitory oligodeoxyribonucleotides. Immunol Res 39 (2007) 4-14
20. Haas T., Metzger J., Schmitz F., Heit A., Muller T., Latz E., and Wagner H. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28 (2008) 315-323. This report demonstrated that the sugar-backbone, not the bases of DNA binds to TLR9 and is sufficient as a ligand to act as a 'mild agonist', and that this agonistic activity is further enhanced by the presence of a CpG motif.
21. Krug A. Nucleic acid recognition receptors in autoimmunity. Handb Exp Pharmacol 183 (2008) 129-151
22. •] expands the list of factor(s) that can modify the self-nonself moiety of DNA, thereby influencing TLR9-mediated descrimination between microbial (nonself) DNA and host (self) DNA.
23. Lee J., Mo J.H., Shen C., Rucker A.N., and Raz E. Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 23 (2007) 27-31
24. Barton G.M., Kagan J.C., and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7 (2006) 49-56
25. Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., and Kim Y.M. The interaction between the ER membrane protein UNC93B and TLR3, 7 and 9 is crucial for TLR signaling. J Cell Biol 177 (2007) 265-275
26. Kim Y.M., Brinkmann M.M., Paquet M.E., and Ploegh H.L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452 (2008) 234-238
27. •].
28. Watarai H., Sekine E., Inoue S., Nakagawa R., Kaisho T., and Taniguchi M. PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc Natl Acad Sci U S A 105 (2008) 2993-2998
29. Asagiri M., Hirai T., Kunigami T., Kamano S., Gober H.J., Okamoto K., Nishikawa K., Latz E., Golenbock D.T., Aoki K., et al. Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis. Science 319 (2008) 624-627
30. Cheng G., Zhong J., Chung J., and Chisari F.V. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci U S A 104 (2007) 9035-9040
31. Opitz B., Vinzing M., van Laak V., Schmeck B., Heine G., Gunther S., Preissner R., Slevogt H., N'Guessan P.D., Eitel J., et al. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 281 (2006) 36173-36179
32. Kumar H., Kawai T., Kato H., Sato S., Takahashi K., Coban C., Yamamoto M., Uematsu S., Ishii K.J., Takeuchi O., et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203 (2006) 1795-1803
33. Sun Q., Sun L., Liu H.H., Chen X., Seth R.B., Forman J., and Chen Z.J. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 (2006) 633-642
34. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007) 501-505
35. Wang Z., Choi M.K., Ban T., Yanai H., Negishi H., Lu Y., Tamura T., Takaoka A., Nishikura K., and Taniguchi T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A 105 (2008) 5477-5482
36. Ye Z., and Ting J.P. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol 20 (2008) 3-9
37. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., Parks R.J., and Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008) 103-107. This report demonstrated that the dsDNA in the cytoplasm activates inflammasome by triggering ASC-dependent caspase-1 activation, resulting in the secretion of IL-1 beta.
38. Fernandes-Alnemri T., Wu J., Yu J.W., Datta P., Miller B., Jankowski W., Rosenberg S., Zhang J., and Alnemri E.S. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14 (2007) 1590-1604
39. Yu J.W., Fernandes-Alnemri T., Datta P., Wu J., Juliana C., Solorzano L., McCormick M., Zhang Z., and Alnemri E.S. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell 28 (2007) 214-227
40. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., and Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25 (2000) 177-181
41. Yasutomo K., Horiuchi T., Kagami S., Tsukamoto H., Hashimura C., Urushihara M., and Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28 (2001) 313-314
42. Morita M., Stamp G., Robins P., Dulic A., Rosewell I., Hrivnak G., Daly G., Lindahl T., and Barnes D.E. Gene-targeted mice lacking the Trex1 (DNase III) 3′ → 5′ DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol 24 (2004) 6719-6727
43. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.A., de Silva U., Bailey S.L., Witte T., Vyse T.J., et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39 (2007) 1065-1067
44. Yang Y.G., Lindahl T., and Barnes D.E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131 (2007) 873-886
45. Zheng L., Dai H., Zhou M., Li M., Singh P., Qiu J., Tsark W., Huang Q., Kernstine K., Zhang X., et al. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat Med 13 (2007) 812-819
46. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., and Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202 (2005) 321-331
47. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., and Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 (2006) 417-428
48. Krieg A.M., and Vollmer J. Toll-like receptors 7, 8 and 9: linking innate immunity to autoimmunity. Immunol Rev 220 (2007) 251-269
49. Baccala R., Hoebe K., Kono D.H., Beutler B., and Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13 (2007) 543-551